We have an unprecedented situation where there is a very rapid development of the vaccine,” said EKPA Rector Thanos Dimopoulos, speaking to in.gr
“It is possible that we will have a vaccine even in the winter,” EKPA Rector Thanos Dimopoulos told in.gr, noting that the next big bet will be its production in huge quantities and its availability at low prices so that they can have access to all countries.
When asked when the second wave of the pandemic will come to our country, the professor of haematology – oncology emphasizes that it is extremely difficult to predict. “It’s likely to be like the flu that starts in October and peaks in February,” he said.
It is reassuring for mutations in coronavirus, as it does not appear to affect vaccine production because it is not in areas where vaccines are being targeted.
In the big question of the day, whether the municipal authorities should open in June, he emphasizes that there are pros and cons and admits that no one can say 100% what is the right approach.
We may have a vaccine in the winter
All scientists have recently turned their attention to both the development of a vaccine and the discovery of the right antiviral drugs to “neutralize” corona.
“We have an unprecedented situation where there is a very rapid development of the vaccine. Where under other circumstances we would wait for one to two years for the discovery of the vaccine “, he emphasizes, in the end, it may come much earlier as a lot of money has fallen in the research part.
We see, he adds, encouraging messages from several research teams, such as Oxford.
“It is possible to have a vaccine even in winter. Of course, the goal is not only to make the right vaccine but also to be able to produce it in large quantities and to be economical. ”
It is not possible to add that the vaccine is an element that divides states into rich and poor.
“Billions must be made. Factories need to be built and pharmaceutical companies need to work together. ”
Should primary schools be opened or not in June?
The Infectious Diseases Commission seems to be giving the “green light” for the return of students to primary schools in early June with the government making the final decision. However, the question of whether or not they should return cannot be answered in a single word by almost any scientist.
“I really don’t think anyone can say 100% what the right approach is. There are pros and cons in both cases.
The special committee dealing with these issues obviously sees no increase in the number of cases and is likely to agree to their opening in June.
It is obvious that the children of these ages cannot meticulously observe the protection measures, however, the children have started to leave the house little by little “, Mr. Dimopoulos emphasizes in in.gr.
In fact, indirectly commenting on the strong criticism that there is a possibility that the schools will be opened, he emphasizes that it is a pity that this issue is a field of differentiation.
A multifactorial approach is needed to treat coronavirus
Thanos Dimopoulos also refers to the major issue concerning the treatment of the virus but also to the difficulty that viral infections have in the therapeutic approach.
“As for the drug, we have to say that viral infections are not like the bacteria where you do an antibiogram and get the right antibiotic.
Viral infections are much more difficult to treat. It took us 30 years for HIV to find the right drugs. ”
He notes that several of the complications observed may not be due to the virus itself but to an organism’s response to the virus that is essentially an inflammatory reaction.
A multifactorial approach is needed to treat the virus, he notes. “We need to find more effective drugs and administer antibodies that block the virus, either in the form of plasma or with monoclonal antibodies made in the lab.”
However, more studies are needed to draw safe conclusions. “With chloroquine, for example, it doesn’t seem to work as well as we would like.
For the mutation of the virus
Regarding possible mutations in the virus and whether they can affect the development of the vaccine, the rector of EKPA is reassuring as the data so far show that the strategy of scientists does not change.
“Currently, experts on this issue are saying that the mutations that are being observed do not seem to affect vaccine production because they are not in areas where vaccines are being targeted. They also say that coronaviruses are more stable in this area than the flu virus.
When will the second wave come to Greece
Greece may have done extremely well in dealing with the pandemic, but scientists and the country’s authorities remain vigilant as it is almost certain that we will have a second wave.
The question of when it will come and whether it will be stronger than the first, the answer is extremely difficult.
“One cannot know when exactly the second wave of the pandemic will come to Greece. We see a low percentage of patients have developed antibodies. It’s likely to be like the flu that starts in October and peaks in February. ”
How should the country be shielded in view of the second wave?
It comes to everyone’s mind, whether they like it or not, the possibility that the Greek government will be forced – in the event of a second wave of the pandemic – to a new lockdown in order to protect vulnerable groups.
Despite what has been done so far, further steps are needed – according to Mr. Dimopoulos – to be even more prepared.
“EODY wants to support, so that there are people who will do more tests and track the cases with which the virus will be diagnosed in someone.
We also need better technological equipment, adequacy in materials for the nursing staff and of course recruitment for the Health Structures “.